患者报告结局测量信息系统固定简表在幼年型肌炎中的心理测量学特性
该研究评估了患者报告结局测量信息系统(PROMIS)儿童自评版和家长代理报告版固定简表在幼年型肌炎(JM)中的信效度。纳入75例JM患儿,自评57例、家长代理报告75例,结果显示PROMIS各量表完成率>96%、Cronbach's alpha>0.8,患者与家长在移动、上肢和疲劳领域一致性中等(ICC>0.5),疼痛干扰、抑郁症状和焦虑的ICC为0.41-0.47。作者认为PROMIS在JM中具有信效度证据,儿童与家长报告差异足够大提示两者均应采集,PROMIS可考虑用于JM的临床和研究。
要点
- PROMIS儿童自评和家长代理报告固定简表在幼年型肌炎中完成率>96%,Cronbach's alpha>0.8。
- 患者与家长在移动、上肢和疲劳领域一致性中等(ICC>0.5),疼痛干扰、抑郁症状和焦虑ICC为0.41-0.47。
- 低疾病活动度和样本量小限制了统计效能,但多个PROMIS量表仍显示结构效度和已知组效度。
核心结论
- PROMIS量表在幼年型肌炎中显示出信效度证据。
- 儿童与家长报告差异足够大,提示两者均应采集。
- PROMIS量表可考虑用于幼年型肌炎的临床和研究。
研究设计与样本
- 纳入8-17岁幼年型肌炎患儿及5-17岁患儿家长,完成PROMIS固定简表(身体功能、疼痛干扰、疲劳、情绪困扰)、PedsQL通用核心量表及风湿病模块。
- 共入组75例幼年型肌炎参与者,按年龄57例完成自评、75例完成家长代理报告。
- 采用Cronbach's alpha评估内部一致性信度,组内相关系数(ICC)评估患者-家长一致性,Spearman相关评估同时效度和结构效度,比较临床不同组PROMIS T评分评估已知组效度。
主要发现
- PROMIS量表可行性好,完成率>96%,内部一致性信度高(Cronbach's alpha>0.8)。
- 患者-家长评估在移动、上肢和疲劳领域一致性中等(ICC>0.5),疼痛干扰、抑郁症状和焦虑的ICC为0.41-0.47。
- 除1个假设关系外,PROMIS与PedsQL-GC/-RM各领域间均呈中等相关(Spearman's rho>0.5),支持同时效度。
- 低疾病活动度和样本量小限制了统计效能,但多个PROMIS儿童自评和家长代理报告量表仍显示结构效度和已知组效度。
临床怎么用
- 作者认为PROMIS量表可考虑用于幼年型肌炎的临床和研究。
- 作者认为儿童与家长报告差异足够大,两者均应采集。
局限性
- 低疾病活动度和样本量小限制了统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Assess reliability and validity of Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric self-report and parent-proxy report fixed short forms in juvenile myositis (JM). METHODS: Children with JM (8-17yo) and parents of 5-17 yo JM patients completed PROMIS measures (Physical Function, Pain Interference, Fatigue, Emotional Distress), PedsQL Generic Core scales and Rheumatology Module (PedsQL-GC/-RM). Internal consistency reliability was assessed via Cronbach's alpha. Patient-parent agreement was assessed via intraclass correlations (ICC). Concurrent and construct validity were assessed via Spearman's correlations between PROMIS versus PedsQL-GC/-RM and clinical/lab data respectively. Known-groups validity was assessed by comparing PROMIS T-scores between clinically distinct JM patients. RESULTS: We enrolled 75 JM participants, with 57 administered self-report and all 75 administered parent-proxy report measures per participant age. PROMIS measures were feasible (>96% completion), with high internal consistency reliability (Cronbach's alpha >0.8). Patient-parent assessments demonstrated moderate agreement (ICC >0.5) for Mobility, Upper Extremity, and Fatigue domains, and smaller correlations (ICC 0.41-0.47) as expected for Pain Interference, Depressive Symptoms, and Anxiety. Concurrent validity was demonstrated by moderate correlation (Spearman's rho >0.5) for all but 1 hypothesized relationships of PROMIS and PedsQL-GC/-RM domains. Although low disease activity and small sample size limited statistical power, construct validity and known-groups validity were demonstrable for multiple PROMIS pediatric self-report and parent-proxy report measures. CONCLUSION: PROMIS measures show evidence of reliability and validity in JM. Child and parent reports differ sufficiently to suggest both should be collected. PROMIS measures can be considered for clinical and research use in JM.
引用
- Ardalan K, Marques MC, Cella D, et al. Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis. Semin Arthritis Rheum. 2025. PMID: 39933204. doi:10.1016/j.semarthrit.2025.152649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。